1192 HIGH SUSTAINED VIROLOGICAL RESPONSE RATES WITH RESPONSE-GUIDED DANOPREVIR PLUS PEGINTERFERON ALFA-2A (40KD) AND RIBAVIRIN IN TREATMENT-NAIVE, HCV GENOTYPE 1 PATIENTS: ATLAS STUDY FINAL RESULTS
Marcellin, P, Cooper, C, Balart, L.A, Larrey, D.G, Box, T.D, Yoshida, E, Lawitz, E, Buggisch, P, Ferenci, P, Weltman, M, Labriola-Tompkins, E, Le Pogam, S, Nájera, I, Thomas, D.N, Hooper, G, Shulman, N, Zhang, Y, Navarro, M.T, Lim, C.Y, Brunda, M, Yetzer, E.S, Terrault, N
Published in Journal of hepatology (01.04.2012)
Published in Journal of hepatology (01.04.2012)
Get full text
Journal Article